Brain-derived neurotrophic factor (BDNF) potentiates excitatory synapses in a variety
Introduction
Neurotrophins are crucial for the survival and differentiation of neurons (Levi-Montalcini, 1987; Lewin and Barde, 1996) and are known to modulate a variety of synapses (McAllister et al., 1999; Poo, 2001) . Neurotrophins serve long-term trophic functions by regulating expression of synaptic proteins (Wang et al., 1995; Narisawa-Saito et al., 1999; Loeb et al., 2002) and maturation of synaptic properties (Wang et al., 1995; Liou et al., 1997) . They also acutely modulate the efficacy of basal synaptic transmission at developing neuromuscular junctions in cell cultures (Lohof et al., 1993) and at central excitatory synapses in hippocampal and cortical cultures (Lessmann et al., 1994; Levine et al., 1995; Li et al., 1998) , acute slices (Kang and Schuman, 1995; Akaneya et al., 1997) , and in vivo (Messaoudi et al., 1998) . In addition, brainderived neurotrophic factor (BDNF), a member of the neurotrophin family, plays an important role in activity-induced longterm potentiation (LTP) in the hippocampus (Korte et al., 1995; Figurov et al., 1996; Patterson et al., 1996) .
The mechanisms for neurotrophin-induced synaptic modulation have been most extensively studied at excitatory synapses. With a few exceptions (Levine et al., 1995; Kovalchuk et al., 2002) , neurotrophin effects have been attributed to increased presynaptic transmitter release. They have also been associated with activation of Trk receptor tyrosine kinase (Lohof et al., 1993) , PI-3 (phosphoinositide-3) kinase (Yang et al., 2001 ) and MAP (mitogen-activated protein) kinase (Jovanovic et al., 1996) , and elevation of cytoplasmic Ca 2ϩ (Zhang and Poo, 2002) . The downstream actions of these cytoplasmic signals may increase phosphorylation of synaptic vesicle-associated proteins (Jovanovic et al., 2000) , causing enhanced transmitter loading, vesicle mobilization, or secretion at excitatory synapses. Interestingly, the existing evidence indicates that neurotrophins reduce the efficacy of inhibitory transmission (Kim et al., 1994; Tanaka et al., 1997; Frerking et al., 1998; Brunig et al., 2001 , Rivera et al., 2002 . Together, these reports suggest that BDNF-induced acute synaptic modulation is specific to presynaptic neuron type. In addition, the effect of BDNF at excitatory synapses is specific to postsynaptic cell type. In hippocampal cultures, BDNF induces elevated glutamate release at synapses with glutamatergic (E) but not GABAergic (I) postsynaptic cells (Schinder et al., 2000) . Analogously, LTP can be induced in hippocampal cultures (Bi and Poo, 1998) and slices (McMahon and Kauer, 1997; Maccaferri et al., 1998 ) with glutamatergic but not GABAergic postsynaptic cells. It is unknown whether the modulatory effect of BDNF on GABAergic synapses is also specific to the postsynaptic cell type.
In the present study, we demonstrated that BDNF exerts opposite modulatory effects on glutamatergic and GABAergic synapses in hippocampal cultures. In addition, we found that the effect of BDNF on GABAergic synapses depends on the postsynaptic cell type. Although BDNF modulates presynaptic transmitter release at GABAergic synapses on both glutamatergic and GABAergic postsynaptic cells, BDNF acts postsynaptically to reduce inhibition only at GABAergic synapses on GABAergic postsynaptic cells. This action is mediated by a BDNF-induced shift in the reversal potential (E IPSC ) for Cl Ϫ currents toward more positive levels, an effect that correlates with a rapid downregulation of K ϩ -Cl Ϫ cotransporter activity. These findings demonstrate a novel mechanism for BDNF modulation of GABAergic synapses.
Materials and Methods
Culture preparation. Low-density cultures of dissociated hippocampal neurons were prepared from embryonic day 18 (E18) to E20 rat embryos as described previously (Bi and Poo, 1998) . Hippocampi were trypsinized for 20 min at 37°C and then gently triturated. Dissociated neurons were plated at 25,000 -100,000 cells/ml on poly-L-lysine-coated glass coverslips in 35 mm Petri dishes. The plating medium used was DMEM (BioWhittaker, Walkersville, MD) supplemented with 10% fetal calf serum (Hyclone, Logan, UT), 10% Ham's F-12 with glutamine (BioWhittaker) and 50 U/ml penicillin-streptomycin (Sigma, St. Louis, MO). The culture medium was supplemented with 20 mM KCl 24 hr after plating. Both glia and neurons are present under these conditions. Neurons were recorded after 10 -14 d in culture.
Electrophysiology. Double whole-cell perforated-patch or breakthrough recordings were simultaneously made from pairs of reciprocally connected neurons in culture as described previously (Bi and Poo, 1998) . Recording pipettes were prepared from glass microcapillaries (VWR Scientific, Brisbane, CA) with a resistance of 2-4 M⍀. Internal solutions differed in various experiments and are described in detail below. All experiments were performed at room temperature in an external bath solution containing the following (in mM): 150 NaCl, 3 KCl, 3 CaCl 2 , 2 MgCl 2 , 10 HEPES, and 5 glucose, pH 7.4 (310 mOsm). Neurons were visualized by phase-contrast optics (Nikon Diaphot; Nikon, Tokyo, Japan). Recordings were performed with two patch-clamp amplifiers (Axopatch 200B; Axon Insturments, Foster City, CA). Signals were filtered at 5 Hz using amplifier circuitry. Data was acquired and analyzed using Axoscope 8.0 (Axon Instruments). Series resistance was assessed at 5 min intervals and compensated at 75% throughout the experiment. Experiments were rejected if changes in series resistance exceeded 10%. Unless otherwise noted, average values are expressed as mean Ϯ SEM, and statistical analyses were performed using one-tailed Student's t tests, either paired or unpaired as noted. BDNF (PeproTech, Rocky Hill; NJ) was added directly to the recording bath for a final concentration of 100 ng/ml in experiments that did not require perfusion of the culture. When cells were being continuously perfused, the bath solution was recycled once BDNF had been added for a final concentration of 100 ng/ml. We found no difference in results for these two procedures of BDNF application. All recordings of currents induced by focally applied transmitter were made with constant perfusion to avoid desensitization of transmitter receptors and toxicity to the cell.
Recordings of EPSCs and IPSCs. To assess synaptic connectivity, the presynaptic neuron was stimulated at a low frequency (0.03-0.05 Hz) with a 1 msec step depolarization from Ϫ70 to ϩ30 mV in voltage-clamp mode. We identified EPSCs and IPSCs by their characteristic decay times (ϳ10 and 40 msec, respectively), reversal potentials (Ϫ5 to 5 mV and Ϫ70 to Ϫ40 mV, respectively), and, in some cases, their sensitivity to 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 M) or bicuculline methiodide (15 M; Research Biochemicals, Natick, MA), respectively. Experiments were performed only if both the presynaptic and postsynaptic cell type could be identified. For most recordings, neurons were voltage clamped (V h ) at Ϫ70 mV, resulting in inward currents for both EPSCs and IPSCs. For perforated-patch recordings of EPSCs and IPSCs, pipettes were tip filled with internal solution and then backfilled with internal solution containing gramicidin D (25 g/ml; Sigma) or amphotericin B (200 g/ml; Calbiochem, San Diego, CA). The internal solution for gramicidin D perforated-patch recordings contained the following (in mM): 150 KCl and 10 HEPES. The internal solution for amphotericin B perforated-patch recordings contained the following (in mM): 154 K-gluconate, 9 NaCl, 1 MgCl 2 , 10 HEPES, and 0.2 EGTA. All perforatedpatch recordings of EPSCs were made with amphotericin B. Perforatedpatch recordings of IPSCs were made with either gramicidin D or amphotericin B. Gramicidin D forms pores permeable to monovalent cations and small uncharged molecules but not to Cl Ϫ , permitting reliable recordings of GABAergic currents (Kyrozis and Reichling, 1995; Owens et al., 1996) formed with amphotericin B or gramicidin D perforated-patch or breakthrough whole-cell recording. The synaptic reversal potential of IPSCs was determined by varying the V h of the postsynaptic cell in 5-10 mV increments from Ϫ80 to Ϫ50 mV and measuring the resulting IPSC amplitude. A best-fit line for the current-voltage ( I-V) relationship was calculated using a linear regression, and the interpolated intercept of this line with the abscissa was taken as the reversal potential. The slope of the same line was taken as the respective slope conductance.
Recordings of transmitter-induced currents. After the cell type was determined using synaptically evoked responses, glutamate or GABA was focally applied at the soma of the identified cell, and transmitter-induced currents were recorded by puffing transmitter pulses (100 mM, 1 msec, 10 -20 psi) through a micropipette (2 M⍀; VWR Scientific) at a 30 sec interval, using an electrically gated Picospritzer (General Valve, Fairfield, NJ). Glutamate (100 mM) was puffed at a 90 sec interval to reduce potential toxic effects on the cells. All transmitter-induced currents were recorded using the perforated-patch method. Either gramicidin D or amphotericin B was used as the perforating agent for GABA-induced current recordings, with similar results. All glutamate-induced current recordings were performed with amphotericin B perforation.
Recordings of miniature EPSCs and IPSCs. After the cell type had been identified using the criteria described above, the bath solution was replaced with one that contained tetrodotoxin (TTX) (1 M), 0.05% BSA, and either bicuculline (15 M) or CNQX (10 M) to record miniature EPSCs (mEPSCs) or mIPSCs, respectively. Recordings of mEPSCs were made using the amphotericin B perforated-patch method described above. Because the amplitudes of mIPSCs with V h of Ϫ 70 mV were too small to be consistently detected, mIPSCs were recorded as outward currents at V h of 0 mV. To stabilize the cells while voltage clamped at 0 mV, mIPSCs were recorded in breakthrough mode using whole-cell internal solution (described above) that replaced K Immunocytochemistry. Hippocampal cultures prepared as described above were washed with PBS two to three times before and after each of the following steps. Cultures were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 for 20 min, incubated for 90 min with rabbit anti-KCC2 antibody (Upstate Biotechnology, Lake Placid, NY) diluted (1:200) in 2% PBS-BSA, incubated for 60 min with Alexa Fluor 568 goat anti-rabbit secondary antibody (Molecular Probes, Eugene, OR) diluted (1:1000) in 2% PBS-BSA, and mounted with Prolong Antifade (Molecular Probes). Images of fluorescent neurons were acquired using a Leica (Nussloch, Germany) confocal imaging system (TCS SP) equipped with a krypton gas ion laser and a Leica inverted microscope (DM IRBE) fitted with a Leica 40ϫ objective (PL Apo; 1.25-0.75 oil immersion).
Results
The effect of BDNF on GABAergic synapses depends on the postsynaptic cell type Synaptic modulation by BDNF was examined at both glutamatergic and GABAergic synapses in cultures of dissociated rat hippocampal neurons. Simultaneous recordings of two reciprocally connected neurons were made using whole-cell recording methods. Because the BDNF effect on glutamatergic synapses has been shown to be target-cell specific (Schinder et al., 2000) , we recorded from neuron pairs only when both presynaptic and postsynaptic cells could be unequivocally identified as either glutamatergic (E) or GABAergic (I). The cell type of the neuron was determined by sequentially recording synaptic currents evoked by stimulation of each neuron in the pair. EPSCs and IPSCs were identified by their characteristic time course, reversal potential, and, in some cases, their sensitivity to CNQX and bicuculline, which block AMPA and GABA A receptors, respectively (see Materials and Methods).
In the first set of experiments, we examined the effects of bath-applied BDNF on the efficacy of both glutamatergic and GABAergic synapses. Recordings were made with gramicidin D or amphotericin B perforated patch or with breakthrough whole cell. Similar results were obtained with all three methods as long as a stable control recording was achieved before the application of BDNF (see Materials and Methods). Presynaptic specificity of the action of BDNF was determined by comparing the effects of BDNF on EPSCs and IPSCs observed only in glutamatergic neurons (E3 E vs I3 E). Postsynaptic specificity of BDNF actions was determined by comparing the effects of BDNF on IPSCs observed in glutamatergic versus GABAergic neurons (I3 E vs I3 I). Neurons were voltage clamped at Ϫ70 mV, at which most IPSCs were inward currents with distinctively longer decay times than EPSCs. After a 10 -20 min control period of stable EPSC or IPSC recording, BDNF (100 ng/ml) was applied to the culture by either direct bath addition or constant perfusion. In agreement with previous findings (Lessmann et al., 1994; Levine et al., 1995; Li et al., 1998; Schinder et al., 2000) , the amplitude of EPSCs recorded at E3 E synapses increased within the first 10 -15 min and reached a final level of 129 Ϯ 7.3% (n ϭ 12) (Fig. 1A ,D,E) of the control level. In contrast, the amplitude of IPSCs recorded from I3 E synapses showed a slight reduction over the same time course (87 Ϯ 4.5% of the control; n ϭ 19) (Fig. 1B ,D,E), suggesting a differential BDNF effect that depends on the presynaptic cell type. Surprisingly, the amplitude of IPSCs recorded from I3 I synapses showed a marked increase in response to BDNF (154 Ϯ 6.7% of the control; n ϭ 20), starting within 5-10 min after the addition of BDNF ( Fig. 1C-E) , indicating a postsynaptic cell-type specificity for BDNF modulation of IPSCs. This increase in the amplitude of inward (depolarizing) IPSCs represents a reduction of inhibition at these synapses. Together, these experiments indicate that the modulation of synaptic The presynaptic cells were stimulated at 0.05 Hz, and each data point shows the amplitude of a PSC normalized against the average amplitude (dotted line) during the last 10 min of control period (t ϭ Ϫ10 to 0 min). At t ϭ 0, BDNF (100 ng/ml) was added (black line). V h of Ϫ70 mV. Insets, Sample traces of PSCs recorded during the control period and 10 -20 min after adding BDNF. A, Example of EPSCs in a glutamatergic neuron (E3 E) using amphotericin B perforated whole-cell recording. B, Example of IPSCs in a glutamatergic neuron (I3 E), using amphotericin B perforated recording. C, Example of IPSCs in a GABAergic neuron (I3 I), using gramicidin D perforated recording. D, Summary of all experiments on BDNF effects at E3 E, I3 E, and I3 I. Events averaged over 4 min bins and normalized to the last 10 min of the control period. Data points represent mean Ϯ SEM. E, Scatter plot showing the extent of BDNF-induced modulation of individual synapses. Modulation factor is defined as the ratio between the mean PSC amplitude observed 15-30 min after the onset of BDNF application and the mean PSC amplitude during the control period. The average factor was 1.29 Ϯ 0.07 at E3 E (n ϭ 12; p Ͻ 0.0001; paired t test), 0.87 Ϯ 0.05 at I3 E (n ϭ 19; p Ͻ 0.0001), and 1.54 Ϯ 0.07 at I3 I (n ϭ 20; p Ͻ 0.0001). For inhibitory synapses, there was no significant difference between recordings made with gramicidin D (white circles) or amphotericin B (gray circles) ( p ϭ 0.08 and p ϭ 0.22, I3 I and I3 E, respectively; unpaired t test).
transmission by BDNF is unique to each of four different synaptic configurations, suggesting both presynaptic and postsynaptic celltype specificity of BDNF action.
BDNF effects on GABA-induced currents
To determine whether the postsynaptic cell-type specificity of the effect of BDNF on IPSCs reflects a postsynaptic mechanism, we examined the effect of bath-applied BDNF on membrane currents induced by focally applied transmitter. Pairs of neurons were patched and identified. A GABA-or glutamate-containing micropipette was positioned near the surface of the soma, the transmitter was pressure ejected with a 1 msec pulse at regular intervals (see Materials and Methods), and membrane currents were recorded (at V h of Ϫ70 mV) before and after application of BDNF. We found that BDNF treatment caused an increase in the amplitude of inward GABA-induced currents (I GABA ) recorded from GABAergic cells, with a time course and extent of increase similar to that observed for IPSCs at I3 I synapses (Fig. 2 A, B) . The persistence of the BDNF effect was examined by monitoring the amplitude of I GABA after removing BDNF by perfusion with fresh culture medium. In three of four cases, we found that the elevated I GABA persisted for as long as a stable recording was made (5-15 min after washout). In contrast, BDNF had no effect on I GABA or glutamate-induced currents (I glu ) recorded from glutamatergic cells (Fig. 2 A, B) . This demonstrates a selective susceptibility of GABAergic neurons to BDNF-dependent modulation of I GABA , consistent with a potential postsynaptic BDNF effect at I3 I synapses. The lack of any BDNF-induced change in I glu at glutamatergic neurons is consistent with a presynaptic mechanism for BDNF action on EPSCs at E3 E synapses, whereas the lack of change of I GABA in glutamatergic neurons confirms the postsynaptic specificity of the BDNF effect on IPSCs.
BDNF acts postsynaptically through TrkB receptors
To determine whether the observed BDNF effect on I GABA recorded from GABAergic cells was attributable to activation of TrkB receptors, we examined the effect of BDNF on cells that were preincubated with an antibody raised against the extracellular domain of the TrkB receptor (amino acids 160 -320; rabbit polyclonal). We found that preincubation with TrkB antibody for 15-20 min before recording blocked BDNF modulation of I GABA amplitudes recorded from GABAergic cells (Fig. 2C) . Preincubation with rabbit IgG had no effect on the BDNF-induced elevation of the I GABA amplitude (Fig. 2C) . The tyrosine kinase inhibitor K252a is commonly used to demonstrate TrkB receptor involvement in an observed BDNF effect. We found that, in the presence of K252a, BDNF caused a marked decrease in I GABA amplitude (data not shown), indicating that tyrosine kinase activity may be involved in the BDNF effect. However, K252a is a general tyrosine kinase inhibitor, and both the K ϩ -Cl Ϫ cotransporter 2 (KCC2) and GABA A receptors are known to be regulated by tyrosine kinase activity (Dunne et al., 1998; Kelsch et al., 2001; Brandon et al., 2002) . Thus, the above K252a effect may result from multiple actions on other tyrosine kinases besides TrkB.
BDNF effects on mIPSCs also indicate postsynaptic modulation
To further study the loci of BDNF-induced synaptic modulation, mIPSCs and mEPSCs were analyzed before and after BDNF treatment. Functional identification of the postsynaptic cell type as glutamatergic or GABAergic was made before selective recording of mIPSCs or mEPSCs, using action potential blocker TTX, together with CNQX or bicuculline, respectively. At E3 E synapses, the frequency of mEPSCs increased markedly after the BDNF treatment (202 Ϯ 24% of the control), whereas the mEPSC amplitude distribution remained unchanged (Fig.   Figure 2 . The effects of BDNF on transmitter-induced currents. A, Example of I GABA recorded from GABAergic (top) and glutamatergic (middle) cells and I glu recorded from glutamatergic cells (bottom). I GABA were recorded using gramicidin D, and I glu were recorded using amphotericin B. BDNF was added at t ϭ 0. B, Summary of the normalized amplitude of I GABA and I glu at various times before and after BDNF treatment (black bar). At GABAergic cells, BDNF caused an increase in I GABA amplitude (164 Ϯ 13% of control), but at glutamatergic cells, BDNF caused no significant change in I GABA or I glu amplitude (94 Ϯ 10 and 92 Ϯ 6%, respectively). No significant difference was found between I GABA recorded with gramicidin D and amphotericin B, and the data were pooled. C, Summary of the average BDNF effect on transmitter-induced currents. Modulation factor defined as the ratio between the mean transmitter-induced current amplitude 10 -20 min after BDNF application and that during the last 10 min of the control period. BDNF caused an increase in I GABA recorded from GABAergic cells (1.54 Ϯ 0.15; p Ͻ 0.001; n ϭ 10), but this effect was blocked in cells that had been preincubated with a TrkB antibody (20 g/ml; 1.09 Ϯ 0.08; n ϭ 5; p Ͼ 0.1). Preincubation with rabbit IgG (50 g/ml) did not block the BDNF effect (1.96 Ϯ 0.43; n ϭ 4; p Ͻ 0.05). Glu, Glutamate; ab, antibody.
3 A, D). These results are consistent with previous reports (Lessmann et al., 1994; Li et al., 1998; Schinder et al., 2000) .
The amplitude of inward mIPSCs recorded with V h of Ϫ70 mV was too small to be consistently detected above the noise level because the V h was only slightly more negative than the E IPSC for most cells. Recording with much more negative V h increases the observed size of inward currents but is damaging to the cell. Therefore, mIPSCs were recorded at V h of 0 mV as amplified outward currents (see Materials and Methods). We found that BDNF caused a rapid increase in the mIPSC frequency at I3 E synapses (193 Ϯ 45% of controls), without significant change in the distribution of mIPSC amplitudes (Fig. 3 B, D) . This is in sharp contrast to the BDNF-induced reduction of IPSC amplitude at I3 E synapses, because an increased mini-frequency usually suggests an increased release probability. As discussed later, however, the disparate changes in spontaneous and evoked release are not unprecedented.
When recording outward mIPSCs at I3 I synapses (V h of 0 mV), we found that BDNF caused a reduction of the mIPSC amplitude (79 Ϯ 1% of controls) and a marked decrease in the mIPSC frequency (30 Ϯ 9% of controls) (Fig. 3C,D) . The change in mIPSC amplitude is consistent with a postsynaptic effect. This BDNFinduced reduction of outward mIPSC currents at V h of 0 mV is reconciled with the previous finding of increased inward IPSCs and I GABA at Ϫ70 mV if both resulted from a BDNF-induced shift in the reversal potential of Cl Ϫ currents toward more positive levels. The reduction of mIPSC frequency could in principle result from either a reduction in the release probability or, indirectly, the reduction in mIPSC amplitudes. Because of the skewed amplitude distribution of mIPSCs toward smaller events, reduction in mIPSC amplitudes would result in a disproportionately large decrease in the perceived frequency as a result of a loss of events with amplitudes below the detection threshold. To further test the latter possibility, mIPSC were recorded at I3 E or I3 I synapses at different clamping voltages ranging from 0 to Ϫ15 mV in 5 mV decrements. We found that the decrease in mIPSC amplitude as the membrane potential approached the reversal potential was accompanied by a progressive decrease in the observed mIPSC frequency (Fig. 3E) , in a manner that is quantitatively consistent with the idea that the observed decrease in mIPSC frequency and amplitude reflects a change in amplitude alone. The extent of the observed decrease in mIPSC frequency attributable to amplitude change could also have masked the presynaptic BDNF effects. In two cases in which we were able to record mIPSCs from GABAergic cells at Ϫ70 mV, we indeed observed a robust increase in mIPSC frequency (data not shown; see Materials and Methods), suggesting that BDNF similarly elevates spontaneous presynaptic transmitter release at all three synapse types.
Differential BDNF effects on IPSCs at I3 I and I3 E synapses
Changes in the amplitude of IPSCs or GABA-induced membrane currents may result from a change in membrane conductance or in the driving force for Cl Ϫ ions. Changes in membrane conductance could reflect presynaptic or postsynaptic modifications, e.g., changes in transmitter release or in response properties of GABA A receptors, respectively. Changes in the driving force, however, could result directly from changes in the postsynaptic Cl Ϫ concentration ([Cl Ϫ ] i ), altering the reversal potential for IPSCs (E IPSC ). To determine the mechanism underlying the Ϫ70 mV) . B, Example of mIPSCs at an I3 E synapse in the presence of TTX and CNQX, using breakthrough whole-cell recording at V h of 0 mV (see Materials and Methods). Amplitude distribution shows no significant difference in mIPSC amplitudes at I3 E before and after BDNF treatment ( p ϭ 0.40; Kolmogorov-Smirnov test). C, Example of mIPSC at I3 I synapse, recorded similar to that described in B. Amplitude distributions show a significant difference before and after BDNF treatment ( p ϭ 0.008; Kolmogorov-Smirnov test). D, Summary of BDNF-induced changes in mPSC amplitude and frequency at E3 E (n ϭ 8), I3 E (n ϭ 7), and I3 I (n ϭ 4) synapses. Each bar represents the mean amplitude or frequency 15-30 min after the onset of BDNF treatment, normalized to the mean amplitude or frequency during the control period. Significant differences are indicated by asterisks (frequency, p Ͻ 0.01; amplitude, p Ͻ 0.001; ANOVA; Scheffe post hoc test). E, Recording of mIPSCs while changing V h from 0 to Ϫ15 mV in 5 mV steps. Amplitude and frequency averaged over 1 min bins and normalized to the first 5 min of the recording (t ϭ 0 -5 min). At t ϭ 25 min, bicuculline (Bic) was added to the recording solution.
postsynaptic BDNF effect on IPSCs, the total membrane conductance and E IPSC were measured before and after BDNF treatment. During the control period and at 10 -20 min after BDNF treatment, recordings of IPSCs were made at different membrane potentials from Ϫ80 to Ϫ40 mV. The I-V relationship was used to determine the slope conductance and E IPSC for each cell. Measurements were made for IPSCs recorded from both GABAergic and glutamatergic cells. As shown in Figure 4 , BDNF caused a shift in E IPSC toward more positive levels at I3 I synapses (Fig.  4 A, C,D) but had no consistent effect on E IPSC recorded at I3 E synapses (Fig. 4 B-D) . We also noted that, although the E IPSC recorded showed a large cell-to-cell variation, BDNF consistently induced a similar degree of change in E IPSC at I3 I synapses (Fig. 4C) . Thus, these postsynaptic GABAergic neurons appear to be more susceptible to [Cl Ϫ ] i modulation by BDNF than the glutamatergic neurons. We found an overall decrease in the slope conductance induced by BDNF at both synapse types, with a slightly larger decrease observed at I3 E than I3 I synapses, although the difference was not statistically significant (Fig.  4 D) . These findings also account for the apparent difference in the BDNF effects on IPSCs versus mIPSCs at I3 I synapses described above. Shifts in E IPSC toward more positive values would increase the amplitude of inward IPSCs (recorded at Ϫ70 mV) (Fig. 1C-E ) and decrease the amplitude of outward mIPSCs (recorded at 0 mV) (Fig. 3C,D) .
A BDNF-induced modulation of E IPSC at I3 I synapses raises the question of whether endogenous levels of BDNF are involved in maintaining or regulating E IPSC . To test this, we recorded E IPSC from I3 I synapses before and after acutely blocking endogenous BDNF activity using a TrkB receptor antibody specific to the extracellular domain of the receptor and shown previously to functionally block BDNF activation (Fig. 2C) . Acutely blocking endogenous BDNF activity caused no significant change in E IPSC but caused a decrease in conductance (Fig. 4 D) . This suggests that acute change in the basal level of endogenous BDNF activity is not sufficient to modify E IPSC , although it may be sufficient to modify synaptic conductance. This finding does not rule out potential effects of higher levels of endogenously secreted BDNF on E IPSC under some physiological conditions, e.g., high-frequency neuronal firing (Balkowiec and Katz, 2002) .
BDNF-induced shift in E IPSC requires KCC2 activity
The low [Cl Ϫ ] i characteristic of mature neurons is attributed primarily to KCC2 K ϩ -Cl Ϫ cotransporter activity, which is known to be responsible for setting E IPSC (Thompson and Gahwiler, 1989; Kaila, 1994) and for the developmental switch of GABAergic transmission from excitation to inhibition (Owens et al., 1996; Ehrlich et al., 1999; Rivera et al., 1999; Ganguly et al., 2001) . During development, increased expression and activation of KCC2, the K ϩ -Cl Ϫ cotransporter predominant in neurons (Payne et al., 1996) , lowers [Cl Ϫ ] i and drives E IPSC toward more negative levels, resulting in inhibitory actions by GABA. To test whether KCC2 is involved in BDNF-induced modulation of IP- A 2 and B 2 . The lines represent the best linear fit of data before (black line, black circles) and after (dashed line, white circles) BDNF treatment, its abscissa-intercept determines the E IPSC , and its slope is taken as the synaptic conductance. C, Summary plots showing E IPSC at I3 I and I3 E synapses before (Ϫ) and after (ϩ) BDNF treatment for individual recordings performed with gramicidin D (gray triangles) or amphotericin B (black triangles). There was no significant difference between data obtained by the two methods at either I3 I or I3 E synapses ( p ϭ 0.27 and 0.42, respectively; unpaired t test). D, Summary plots of acute changes in E IPSC (in millivolts) and decrease in synaptic conductance (percentage) after adding BDNF (100 ng/ml), at I3 I (n ϭ 21) and I3 E (n ϭ 8) synapses, or removing endogenous BDNF activity by adding TrkB antibody (2 g/ml; TrkB-ab) at I3 I synapses (n ϭ 4). At I3 I versus I3 E, significant difference was found between the BDNF effects on E IPSC ( p Ͻ 0.0001; unpaired t test) but not between BDNF effects on conductance ( p ϭ 0.12; t test). TrkB antibody had no significant acute effect on E IPSC at I3 I ( p Ͼ 0.1; t test).
SCs, we treated hippocampal cultures with furosemide (100 m), an antagonist of K ϩ -Cl Ϫ cotransporters (Thompson and Gahwiler, 1989; Payne et al., 1996; Payne, 1997; Jarolimek et al., 1999) , for 10 -15 min before the addition of BDNF. Furosemide treatment by itself caused a marked shift in E IPSC toward more positive levels at I3 I synapses, evidenced by a decrease in outward IPSC amplitude and an increase in inward IPSCs (Fig. 5A) . Subsequent BDNF treatment, however, resulted in no additional alteration in IPSC amplitude or E IPSC at these synapses, suggesting that furosemide-sensitive K ϩ -Cl Ϫ cotransport is involved in the modulation of E IPSC by BDNF (Fig. 5 A, C) . In contrast, furosemide treatment by itself had no significant effect on E IPSC at I3 E synapses (Fig.  5B) , and the effect of subsequent BDNF treatment on IPSCs was not altered by the presence of furosemide (Fig. 5 B, C) . These findings suggest that the postsynaptic modulatory action of BDNF at I3 I synapses is mediated through downregulation of furosemide-sensitive K (Fig. 4C) ], suggesting that the absence of a BDNF effect in furosemide-treated cells was unlikely to be caused by a ceiling effect for [Cl Ϫ ] i elevation.
Furosemide is also known to block other cotransporters, including the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC) and KCC1. Therefore, to further determine whether the effect on E IPSC by furosemide was primarily attributable to a block of KCC2 activity, we tested the effect of furosemide on E IPSC sensitivity to changes in external (Payne, 1997; DeFazio et al., 2000) . Thompson and Gahwiler (1989) (Fig. 5D, top) . The effect was reversed after the [K ϩ ] o was returned to 3 mM. In the presence of furosemide, reduction of [K ϩ ] o had no effect on [Cl Ϫ ] i (Fig. 5D, bottom) . These results are consistent with a prevalent furosemide-sensitive KCC2 cotransporter activity in these neurons. To further test for the presence of KCC2 in these neurons, immunocytochemical experiments were performed with a rabbit anti-KCC2 antibody. . E 1 , Specific staining for KCC2 in these neurons using a KCC2 antibody as the primary antibody with cell-to-cell variation in KCC2 staining intensity. E 2 , Control staining in parallel cultures showing the level of nonspecific staining with the secondary antibody alone. For the control image, fluorescence intensity gain was increased more than twofold compared with that for specific KCC2 image. Nonspecific staining was restricted to the soma, showing no variation among neurons.
We found specific staining for KCC2 in these cultures, with a large cell-to-cell variation in the staining intensity within the same culture (Fig. 5E ). This is consistent with a variable level of KCC2 expression among a heterogeneous population of neurons.
BDNF effects on IPSCs correlate with KCC2 activity
The above findings suggest that the effect on IPSCs by BDNF at I3 I synapses involves modulation of KCC2 activity. To further test whether differences in the effects on IPSCs by BDNF at I3 I versus I3 E synapses result from differences in KCC2 activity, we compared the effects of either furosemide treatment or changing [K ϩ ] o on E IPSC at GABAergic and glutamatergic postsynaptic cells. Blocking K ϩ -Cl Ϫ cotransporter activity with furosemide caused significant changes in E IPSC at GABAergic but not glutamatergic cells (Fig. 6 A) , suggesting that I3 I and I3 E synapses differ by their postsynaptic K ϩ -Cl Ϫ cotransporter activity. Furthermore, activating KCC2 cotransporters by changing [K ϩ ] o caused significant changes in E IPSC in GABAergic but not glutamatergic cells (Fig. 6 B) , more specifically indicating cell-type differences in KCC2 activity and not other furosemide-sensitive
To determine whether the differences in KCC2 activity alone can account for the differences in BDNF-induced modulation of IPSCs observed at different synapse types, neuron pairs were recorded continuously under the following conditions. First, we recorded the shift in E IPSC induced by changing [K ϩ ] o briefly from 3 to 1 mM, to reveal KCC2 activity. After recording from the same cells for a second control period with 3 mM [K ϩ ] o , we treated the cells with BDNF and measured changes in E IPSC to determine the synapse susceptibility to BDNF-induced modulation (Fig. 6C) . We found that the degree of E IPSC shift induced by low [K ϩ ] o , which reflects the activity of KCC2, correlated strongly with the BDNF responsiveness for each individual cell (Fig. 6 D) , at either I3 I or I3 E synapses.
Discussion
In this study, we first show that, in hippocampal cultures, BDNF has different modulatory effects at glutamatergic and GABAergic synapses: enhancing the amplitude of EPSCs at E3 E synapses but not that of IPSCs at I3 E synapses. Additionally, BDNF has differential effects on IPSCs at I3 E versus I3 I synapses. At I3 E synapses, we found that BDNF slightly attenuated IPSC amplitude, apparently through a reduction of presynaptic evoked GABA release. At I3 I synapses, however, BDNF modified the IPSC amplitude through a shift in E IPSC toward more positive levels, brought about by downregulating postsynaptic KCC2-mediated K ϩ /Cl Ϫ cotransporter activity. The strong correlation between postsynaptic KCC2 activity and susceptibility to BDNF-induced modulation of E IPSC further suggests KCC2 regulation as a primary postsynaptic mechanism underlying the target cell specificity of the effect on GABAergic synapses by BDNF.
Differential BDNF effects on EPSCs and IPSCs
Our findings of the modulatory effects of BDNF at E3 E and I3 E synapses are in general agreement with previous reports on neurotrophin-induced acute synaptic modifications in dissociated cell cultures and slice preparations (Poo, 2001) . Although several reports have shown that BDNF does not acutely modify basal glutamatergic synaptic transmission in slice preparations (Figurov et al., 1996; Tanaka et al., 1997; Frerking et al., 1998) , the discrepancy may reflect differences in the experimental conditions or developmental stages of the preparations (Poo, 2001) . For example, BDNF-induced effects on EPSCs were found to depend on synapse maturity, as gauged by the initial synaptic strength and reliability (Berninger et al., 1999; Schinder et al., 2000) . Previous reports on acute synaptic modulation by neurotrophins have, in general, examined either EPSCs or IPSCs but ) at individual synapses are inversely correlated (correlation coefficient, r ϭ Ϫ0.841; associated probability, p Ͻ 0.001; ordinary least-squares regression). Recordings were made with amphotericin B (white symbols) and gramicidin D (black symbols) at both I3 I (diamonds) and I3 E (circles) synapses.
not both in the same preparation. The present study demonstrates that, for the same developmental stage and experimental conditions, BDNF directly exerts differential synaptic effects by potentiating E3 E and suppressing I3 E transmission.
Postsynaptic cell-type specificity Synaptic modifications have been shown to be specific to the postsynaptic cell type in a number of systems. In hippocampal culture and slice, activity-dependent LTP can be induced at E3 E but not E3 I synapses (Bi and Poo, 1998; Maccaferri et al., 1998, respectively) , apparently attributable to the lack of postsynaptic Ca 2ϩ /calmodulin kinase II in GABAergic cells (Liu and Jones, 1997; Sik et al., 1998) . Similarly, acute BDNF application potentiates presynaptic transmitter release at E3 E but not E3 I synapses (Schinder et al., 2000) , perhaps attributable to a modification of presynaptic terminal susceptibility to neurotrophins through retrograde signaling from the postsynaptic cell. We demonstrated that the effect on IPSCs by BDNF also depends on postsynaptic cell type. The presynaptic and postsynaptic cell-type specificity of the effects of BDNF could play a critical role in maintaining coordinated modifications of excitatory and inhibitory synaptic actions in heterogeneous neuronal populations during development and in mature nervous systems. This targetcell specificity may reflect differences in inhibitory synapse maturation at I3 I versus I3 E synapses, and maturation of inhibitory synapses has been shown to correlate with increased KCC2 expression and to depend on GABAergic activity (Ganguly et al., 2001) .
Presynaptic versus postsynaptic mechanisms
Previous reports have shown that BDNF effects on EPSCs result primarily from increased presynaptic transmitter release (Lohof et al., 1993; Lessmann and Heumann, 1998; Li et al., 1998; Berninger et al., 1999) . However, BDNF effects on IPSCs have been attributed to both presynaptic and postsynaptic mechanisms. Frerking et al. (1998) found that the reduction of inhibitory transmission by BDNF was accompanied by changes in mean variance and paired-pulse depression, indications of presynaptic effects. However, Tanaka et al. (1997) showed that the effect on IPSCs by BDNF depends on postsynaptic tyrosine kinase activity and Ca 2ϩ mobilization, and Brunig et al. (2001) reported BDNF-induced downregulation of GABA A receptor surface expression. Here we showed that BDNF modulation of IPSCs at I3 E synapses most likely results from presynaptic actions that reduce efficacy of GABA release, whereas at I3 I synapses, it is primarily attributable to a postsynaptic shift of E IPSC to more positive levels. We found that BDNF increased frequency of both mEPSCs and mIPSCs, indicating an increase in the presynaptic release probability. This is consistent with the BDNFinduced enhancement of EPSCs at E3 E synapses but not reduction of IPSCs at I3 E synapses, suggesting differential regulation of spontaneous and evoked GABA release by BDNF. Schinder et al. (2000) have shown previously in these cultures that BDNF had no effect on evoked synaptic responses but caused an increase in mEPSC frequency at E3 I synapses. Interestingly, in synaptotagmin-deficient neurons, increased mEPSC frequency accompanied reduced evoked transmitter release (Broadie et al., 1994) . Opposite BDNF effects on spontaneous and evoked release at I3 E synapses may reflect presynaptic regulation of synaptic vesicle proteins, resulting in release modulation similar to that found in synatotagmin-deficient neurons.
In addition to the BDNF-induced changes in presynaptic transmitter release observed at E3 E, I3 E, and I3 I synapses, we also observed BDNF-induced changes in mini amplitude only at I3 I synapses, indicative of a postsynaptic BDNF effect at I3 I synapses. Recordings of I GABA further confirmed the existence of a postsynaptic BDNF effect independently functioning to selectively modulate I GABA at GABAergic cells. The existence of celltype-specific modulation and both presynaptic and postsynaptic BDNF effects allows diverse physiological actions of BDNF on neural networks made of a heterogeneous population of neurons.
BDNF regulates postsynaptic [Cl ؊ ] i at GABAergic synapses At I3 I synapses, BDNF caused a shift in E IPSC toward more positive levels through postsynaptic regulation of a furosemidesensitive Cl Ϫ transporter activity. Previous studies have shown that Cl Ϫ transport plays a critical role in the development of inhibitory synapses (Owens et al., 1996; Ehrlich et al., 1999; Rivera et al., 1999; Ganguly et al., 2001 ) and in maintaining Cl Ϫ homeostasis in mature neurons (Jarolimek et al., 1999) . In many developing nervous systems, age-specific expression of different K ϩ -Cl Ϫ cotransporters renders GABAergic synaptic transmission initially depolarizing and later hyperpolarizing (Ben-Ari, 2002) . Early in development, high NKCC expression levels elevate [Cl Ϫ ] i (Fukuda et al., 1998; Kakazu et al., 1999) . Later, NKCC levels are reduced and KCC2 expression is upregulated, lowering [Cl Ϫ ] i and causing a shift of E IPSC toward more negative levels (Ehrlich et al., 1999) . After GABAergic transmission switches from depolarizing to hyperpolarizing, KCC2 normally maintains low [Cl Ϫ ] i . However, studies on mature neurons have also shown that the efficacy of GABAergic transmission may be altered through modulation of K ϩ -Cl Ϫ cotransport and subsequent changes in [Cl Ϫ ] i . Thompson and Gahwiler (1989) showed that, in hippocampal slice cultures, repetitive lowfrequency stimulation, furosemide treatment, or changes in [K ϩ ] o all caused a similar reduction in the efficacy of GABAergic synapses through changes in both conductance and driving force for Cl Ϫ . Later studies have shown that both furosemide treatment and [K ϩ ] o can affect KCC2 activity (Payne, 1997) . Furosemide is also known to act on other cotransporters, including NKCC. However, it is unlikely that the furosemide effect observed in the present study results from a block of NKCC activity, because blocking NKCC would result in a decreased [Cl Ϫ ] i , and thus a shift of E IPSC toward more negative rather than positive levels. Furthermore, the hippocampal cultures used for these experiments have already been shown to predominantly express KCC2 (Ganguly et al., 2001) . Rivera et al. (2002) have reported recently that, over the time course of hours, BDNF modulates GABAergic synaptic transmission through a downregulation of KCC2 mRNA and protein. The acute downregulation of K ϩ -Cl Ϫ cotransporter activity within 10 min after BDNF application that we observed appears to involve more rapid posttranslational regulation, although a rapid BDNF-dependent modulation of protein synthesis remains possible (Aakalu et al., 2001) . The postsynaptic specificity of the effect of BDNF could result from differences in postsynaptic TrkB expression. Although previous studies have shown that TrkB expression levels in the hippocampus remain constant from E17 through adulthood (Ivanova and Beyer, 2001 ), cell-to-cell variation in TrkB expression could still arise from varied histories of activity and exposure to BDNF (Haapasalo et al., 2002) . Nonetheless, differences in TrkB expression patterns are unlikely to be the main cause for specificity of BDNF at GABAergic synapses, because the magnitude of the effect of BDNF directly correlates with KCC2 activity levels, as revealed by [K ϩ ] o -sensitive Cl Ϫ transporter activity.
Expression and activity of KCC2 varies with developmental stage (Lu et al., 1999; DeFazio et al., 2000) , neuronal type , and presence of GABAergic activity (Ganguly et al., 2001) . The dependence of KCC2 activity on such diverse factors creates a scenario in which the differential effects on GABAergic synapses by BDNF are specific not only to KCC2 activity but also to the varied factors impinging on KCC2 expression and activity. BDNF and other neurotrophins are involved in a variety of critical nervous system functions, ranging from neuronal development and survival to learning and memory. In addition, they have been linked to pathological conditions such as epilepsy (Esclapez et al., 1997; Biagini et al., 2001; Binder et al., 2001; Scharfman et al., 2002) . Interestingly, previous studies have also shown the importance of Cl Ϫ transport in epilepsy and other pathological conditions, including axonal injury . Here, we report a link between neurotrophin activity and Cl Ϫ transport at GABAergic synapses that provides a promising lead for additional investigation on the regulation of inhibitory mechanisms involved in these pathological conditions.
